BioHealth Innovation
If you are having trouble viewing this email, please click here

January 4, 2019

BHI News Year in Review

Below are BioHealth Innovation News' most popular articles from 2018:

Army Doctors Grew a Soldier a New Ear — On Her Forearm - Time

May 14, 2018

You’ve heard the cliché about wearing your heart on your sleeve. But a group of Army doctors did one better: They grew a new ear on a soldier’s forearm, using cartilage harvested from her ribs.

Read More

Think Resources: BioHealth Innovation - Rich Bendis interview with MCEDC

January 20, 2018

MCEDC talks with Rich Bendis, President and CEO of BioHealth Innovation, about how his organization fuels the science industry in Montgomery County, Maryland.

Read More

BHI CEO Rich Bendis' Opening Presentation at The 2018 BioHeath Capital Region Forum

April 25, 2018

Welcome to the 2018 BioHealth Capital Region Forum: State of the BioHealth Capital Region's EcoSystem

Presented by: Rich Bendis, President & CEO, BioHealth Innovation Inc.

Read More

BioHealth Innovation Appoints Jarrod Borkat as new Vice Chairman of the Board

May 22, 2018

MedImmune Sr. Director, Partnering & Strategy filling role previously held by Emergent BioSolutions CEO, Daniel J. Abdun-Nabi

BioHealth Innovation, Inc. (BHI) announced that its Board of Directors has unanimously approved the appointment of MedImmune Sr. Director, Partnering & Strategy, Jarrod Borkat as new Vice Chairman. MedImmune, the global biologics research and development arm of AstraZeneca, is a Founding Partner of BHI and continues to be a leader in building the BioHealth Capital Region. BHI would like to thank Emergent BioSolutions CEO, Daniel J. Abdun-Nabi, for his service as Vice Chairman. He will remain as a member of the Board of Directors. Mr. Abdun-Nabi also previously served as chairman of the Maryland Life Sciences Advisory Board (LSAB) and currently serves on Maryland Governor Larry Hogan’s Excel Board.

Read More

Galen Robotics Wins BioHealth Capital Region 3rd Annual Crab Trap Competition

April 26, 2018

Competition held during 2018 BioHealth Capital Region Forum

Wilson Sonsini's Charlie Andres and BHI’s Rich Bendis present the team from Galen Robotics their award for winning the 2018 Crab Trap competition

ROCKVILLE, MARYLAND, April 26, 2018 – Galen Robotics, a Johns Hopkins University spinout, was chosen from five finalists as the company with the most commercial potential by judges at the 3rd Annual Crab Trap Competition. This year’s judges included industry leaders Amgen’s Bethany Mancilla, AstraZeneca’s Shaun Grady, Blu Venture’s Dr. Paul Silber, J.P. Morgan’s John T. Rubin, New Enterprise Associates’ Sara Nayeem, Roche’s Robert Silverman, and Sands Capital Ventures’ Stephen Zachary. They were impressed with a presentation by Lead Hardware Engineer, Yunus Sevimli, on Galen Robotics’ low-cost, compact, and intuitive to use novel microsurgical robotic platform designed to assist surgeons with minimally-invasive applications in otolaryngology, neurosurgery and similar critical fields. Galen Robotics is the third Johns Hopkins University spinout to win this competition following LifeSprout (2017) and Sonavex (2016).

Strong presentations also were made by the other finalists--AlgometRx, Cellth Systems, Renalert, and Reveragen Biopharma—whose technologies originated at Children’s National Medical Center, the University of Maryland, and Johns Hopkins University.

Read More

Montgomery County, Maryland-based BeneVir Biopharm, Inc. to be acquired by Janssen Biotech, Inc. for up to $1.04B

May 7, 2018

Company’s announcement latest in recent trend of significant investment in Montgomery County biohealth companies.

BeneVir Biopharm, Inc. (BeneVir), a privately-held Montgomery County biotech company, has entered into an agreement under which it will be acquired by Janssen Biotech, Inc., a Johnson & Johnson company for up to $1.04 billion. Under the terms of the agreement, Janssen will make an upfront cash payment of $140 million at closing of the transaction, plus additional contingent payments of up to $900 million based on achievement of certain predetermined milestones. BeneVir was a client of BioHealth Innovation (BHI) from 2013 until its Series A investment in 2014.

Read More

BioHealth Innovation Receives InBIA January IMPACT Award

March 6, 2018

BioHealth Innovation, Inc. (BHI) has received the International Business Innovation Association (InBIA)’s January 2018 IMPACT Award in Biotech/Cleantech for the management of four spaces for early stage companies: the Germantown Innovation Center, the Rockville Innovation Center, LaunchLabs, and the BHI International Innovation Center. The award is based on a variety of metrics including affiliations and partnerships, application and graduation, facilities, mission and goals. This recognition also enables this innovation activity to be considered with other leading entrepreneurial centers across the country as a finalist for the InBIA’s annual Incubator of the Year Awards.

Read More

Maryland Biotechs Dominate 2018 Vaccine Industry Excellence Awards – BioBuzz

April 23, 2018

More than a dozen biotech companies or researchers from the Maryland biotech cluster, which some have also dubbed ‘Vaccine Alley’, were among the most recognized finalists at this year’s Vaccine Industry Excellence (ViE) Awards in Washington, DC at the World Vaccine Conference. In fact, 15 out of the 54 finalists, or 27%. were from right here in Maryland. This year’s conference was held in Washington, DC so could this have been a case of home court advantage? Probably not. More than likely it’s because this region holds 20% of the top influencers worldwide in vaccine development.

Read More

Supernus Pharmaceuticals to acquire Biscayne Neurotherapeutics for up to $185M - Washington Business Journal

September 17, 2018

Rockville-based Supernus Pharmaceuticals Inc. has reached a deal to acquire Miami-based Biscayne Neurotherapeutics in a deal worth up to $185 million.

Read More

BioHealth Capital Region Industry Compensation Survey™

April 25, 2018

Is your employee compensation package competitive? 

Help us help you.  Complete the 2018 BHCR Industry Compensation Survey by June 1, 2018 to receive an anonymized summary of salaries and benefits specific to positions in biohealth and to this region.  A pdf version of the survey is available here or you can use the online version of the survey to complete your information.  All company specific information will be kept confidential.  This survey is a joint project among BioHealth InnovationWorkSource Montgomery, and UMBC-Shady Grove’s Industrial Organizational Pyschology Program.  If you or your Human Resources colleagues have any questions about the survey, please contact

Read More

Biomaterials Could Extend the Success of Immunotherapies - GEN

January 8, 2018

The use of biomaterials, such as microneedles and nanoparticles, in immunotherapy and vaccine research is a hot topic in bioengineering. But to get the maximum return on investment in these ideas, they need to be seeded among clinicians, according to Christopher Jewell, Ph.D., associate professor in the Fischell Department of Bioengineering at the University of Maryland. Jewell is the principal author on a new paper in Trends in Immunology that reviews the current state of biomaterials research with an eye toward inspiring multidisciplinary teams of engineers and clinicians to solve some of the complex problems in immunology today.

Read More

China-based pharma firm KBP Biosciences plans HQ move to Philly area

January 8, 2018

A drug development company has raised $76 million from investors in China, the United States, and Korea to move its headquarters to the Philadelphia area from Jinan, China, and bring treatments developed by China-based scientists through U.S. clinical testing to patients here.

Read More

TaiRx, Inc. and BioHealth Innovation, Inc. Form TaiRx US to Develop and Commercialize Therapeutics and Precision Medicine Diagnostics

October 22, 2018

TaiRx, Inc and BioHealth Innovation, Inc. (BHI) announced today the formation of TaiRx US, a new joint venture.  The mission of the new company is to develop therapeutics and precision medicine diagnostics focused on the Nodal protein, a critical mediator of aggressive cancer progression and treatment resistance.

TaiRx, Inc and BHI have formed TaiRx US, which will be based in Rockville (Montgomery County), Maryland, to develop and commercialize a unique monoclonal antibody with the potential to reverse drug resistance in various tumor types. The company is also working to develop a companion diagnostic to accurately identify those patients who can best benefit from the therapy.

Read More

PepVax Announces Completion of Efficacy Study with Key Pre-Clinical Data to Validate PVX-009,

January 13, 2018

PepVax, Inc., an early-stage biotechnology company, announced today that it has successfully completed the efficacy study for its lead candidate, PVX-009. The Company is harnessing the power of the immune system to target a specific protein, MAGE A, in an effort to find a treatment for triple negative breast cancer (TNBC).

Read More

Emergent BioSolutions to Acquire Specialty Vaccines Company PaxVax

August 13, 2018

Emergent BioSolutions Inc. (NYSE: EBS) announced today that it has entered into an agreement to acquire PaxVax, a company focused on specialty vaccines that protect against existing and emerging infectious diseases, for an all-cash consideration of $270 million. PaxVax is majority owned by an affiliate of Cerberus Capital Management, L.P.

Read More

Six pediatric device innovators awarded total of $150K at Children’s National 6th Annual Pediatric Device Symposium

September 25, 2018

A total of $150K was awarded to six pediatric cardiovascular innovations during the medical device pitch competition at the 6th Annual Pediatric Device Innovation Symposium hosted by Children's National Health System.  Award winners with Children’s National Vice President Kolaleh Eskandanian (far left) and CEO Kurt Newman, MD, (far right) include:  Ken Nelson, Bardy Diagnostics; Henri Justino, MD, PolyVascular Corp.; Corin Williams, Draper; Doug Vincent, VentriFlo; Joshua Woolley, NuPulseCV; and Kurt Newman, MD, Children’s National Health System. Peca Labs, not pictured, was also an award recipient. Photo credit: Paul Loftland Photograph

Six companies presenting innovative medical devices that address significant unmet needs in pediatric healthcare were awarded a total of $150,000 in grants yesterday in Philadelphia, the Sixth Annual Pediatric Device Innovation Symposiumorganized by the Sheikh Zayed Institute for Pediatric Surgical Innovation at Children’s National Health System.

The “Make Your Medical Device Pitch for Kids!” competition this year focused on pediatric cardiovascular devices, an area where new devices can make a life-changing difference, especially for younger children. The Centers for Disease Control and Prevention estimate that 40,000 children are born annually in the U.S. with a congenital heart defect (CHD) and approximately 1 million U.S. children currently live with a CHD.

The pitch competition was originally slated to award $100,000 in grants; however, because of the judges’ response to the quality and potential of the technologies presented, Children’s National expanded the award grants to $150,000 to include six awardees.

Read More

Altimmune Appoints Mitchel Sayare as Executive Chairman of the Board, and Adds José Ochoa to Its Leadership Team as Chief Business Officer -

July 16, 2018

Altimmune, Inc. (Nasdaq:ALT), a clinical-stage immunotherapeutics company focused on infectious disease, today announced it has appointed Mitchel Sayare, Ph.D., as Executive Chairman of the Board, effective immediately.

Read More

What's next for biotech? - Innovators magazine

January 29, 2018

Innovators Magazine asked some biotech stakeholders what trends they expect to see in their markets this year.

The opinions were published in our special biotechnology edition, which was distributed to delegates at an industry conference in Glasgow this week.

Read More

Biohealth Capital Region aiming for top 3 status - Smart Incentives

April 30, 2018

The Biohealth Capital Region–DC, Maryland and Virginia – plans to be a top 3 biohealth hub in the US by 2023. What will it take to get there?

The Biohealth Capital Region is already a top 5 location as ranked by NIH and venture capital funding, patents, lab space, and jobs. The 1,100 participants at this week’s 2018 Biohealth Capital Region Forum agreed on the area’s strengths: a highly educated and diverse workforce, leading universities and research institutions, strong healthcare organizations, hundreds of companies, and broad-based policy commitment to the biohealth industry.

Read More

Novavax Appoints Rachel King to Board of Directors -

November 5, 2018

Novavax, Inc., (Nasdaq:NVAX) today announced the appointment of Rachel King, Co-Founder and Chief Executive Officer of GlycoMimetics, Inc., to its Board of Directors. In addition to extensive experience as an executive in the biotechnology industry, Mrs. King has also worked in the venture capital side of life sciences, and has held executive positions within a global multinational pharmaceutical company.

Read More

Baltimore medical device startup Perceptive Navigation LLC looks to raise $4 million - Baltimore Business Journal

March 20, 2018

Baltimore medical device firm Perceptive Navigation LLC is looking to raise $4 million in new funding, according to a recent filing with the U.S. Securities and Exchange Commission.

Read More

Solera Health and WellDoc Partner to Offer Health Plans and Employers a Holistic Approach to Diabetes Prevention and ManagementSolera Health will integrate the BlueStar® Digital Therapeutic, a... | Markets Insider

January 20, 2018

Solera Health, an integrated benefit network, and WellDoc®, a leading digital therapeutic company, announced today that WellDoc’s BlueStar® digital therapeutic will join the Solera network as a diabetes management solution of choice. The partnership aligns both companies’ goals to improve the lives of those living with chronic diseases while enhancing clinical results and decreasing overall healthcare costs.

Read More

Montgomery County Council provides $425,000 for fiscal year 2019 operating budget to fund Small Business Innovation Research Matching Grant Program - First County in the US to offer a SBIR matching grant program

May 29, 2018

The Montgomery County Council approved the fiscal year (FY) 2019 operating budget on Thursday, May 24, 2018. Included in the budget is a total of $425,000 for the Small Business Innovation Research (SBIR) Matching Grant Program. The program provides matching fund for businesses that receive federal SBIR and Small Business Technology Transfer (STTR) grants.

Bill 41-17, Economic Development Fund – Small Business Innovation Research and Small Business Technology Transfer Matching Grant Program established a County matching fund for businesses that receive federal SBIR and STTR grants. Councilmember George Leventhal, who serves as chair of the Council’s Health and Human Services Committee and is a member of the Planning, Housing and Economic Development Committee, was the lead sponsor of Bill 41-17. All other Councilmembers were cosponsors.

Read More

Maryland in Top 10 States that Added Jobs (Virginia and DC in Top 30) -

January 30, 2018

Nearly all states added jobs in 2017, but the latest Labor Department data suggests most states experienced slower growth last year than in 2016.

Still, it proved to be a particularly strong year for a select group of states -- 10 of which recorded year-over-year job gains exceeding 2 percent.

Read More

All Eyes on Better Health at CES 2018: Innovation Awards Honoree RightEye Debuts EyeQ System | Business Wire

January 9, 2018

RightEye LLC, an award-winning technology innovator using eye tracking to revolutionize patient care and vision performance, announced today it will be debuting its new RightEye EyeQ system tonight at CES Unveiled Las Vegas at 5:00 p.m. at the Mandalay Bay Shorelines Exhibit Hall in Las Vegas, Nevada. EyeQ gives people a closer look at their health using quick, computer game-style vision tests on an eye-tracking computer. The tests, which only take a few minutes, generate an instant EyeQ Report that provides results in an easy-to-understand format to support discussion with doctors on diagnosis and recommended therapies.

Read More

Press release - KeyGene Licenses University of Wisconsin Sequence-Based Genotyping Patents - Keygene

January 16, 2018

KeyGene and the University of Wisconsin-Madison announced today that they have entered into a service license agreement to practice KeyGene’s patented Sequence Based Genotyping (SBG) methods. Under the agreement, UW-Madison, through its Biotechnology Center (UWBC), is licensed to offer SBG services in all species to research collaborators and clients worldwide.

Read More

BIO 2018 Recap

June 19, 2018

Business partnering, education and networking was the focus of 3500 biohealth industry leaders who attended the BIO International Convention (BIO) Conference earlier this month in Boston. At the event, BIO set the GUINNESS WORLD RECORDS title for the Largest Business Partnering Event with 41,400 partnering meetings. Many of these meetings took place in the pavilion hosted by the Maryland Department of Commerce which included space for meetings BioHealth Innovation, Montgomery County Economic Development Corp (MCEDC), Rockville Economic Development (REDI), the City of Gaithersburg, Viva White Oak, PIC-MC (Montgomery College), University of Maryland Ventures, Johns Hopkins University, Fina BioSolutions, Integrated Pharma Services, Pharmaceuticals International, Inc., Emergent BioSolutions, AsclepiX, and US FDA’s Tech Transfer Office. Others from the BioHealth Capital Region who attended included: ABL, American Gene Technologies, AstraZeneca / MedImmune, Altimmune, BioMarker Strategies, Bytegrid, Children’s National Health, CRBE, Creatv Microtech, GlycoMimetics, IDT Biologica, Immunomics, Intrexon, Leidos Health, MacroGenics, Maryland Tech Council, MaxCyte, Newport Board Group, Novodux Paragon Bioservices, REGENXBIO, MacroGenics, Neuronascent, Scheer Partners, Smithers Avanza, TEDCO, the University of Maryland Baltimore, and the University of Maryland’s Institute of Bioscience and Biotechnology Research.

Read More

Lupin receives FDA approval for generic Tamiflu Capsules

January 16, 2018

Pharma Major Lupin announced that it has received final approval for its Oseltamivir Phosphate Capsules USP, 30 mg (base), 45 mg (base), and 75 mg (base) from the United States Food and Drug Administration (FDA) to market a generic version of Hoffman-La Roche, Inc.’s Tamiflu Capsules, 30 mg, 45 mg, and 75 mg.

Read More

Protenus plans Baltimore hiring push after raising $11M Series B - Baltimore

January 22, 2018

Six months after closing its most recent funding, Protenus reported raising $11 million in Series B funding, and is planning more hiring.

Read More

TEDCO adds five companies to seed portfolio with $600,000 in new investments - Baltimore Business Journal

February 6, 2018

Maryland Technology Development Corp. made new seed investments in five Maryland startup companies, totaling $600,000.

TEDCO has invested hundreds of thousands of dollars in young, growing companies across the state. The state-backed organization has 137 active investments through its seed fund.

Read More

AgriMetis Opens New Lab in Gaithersburg, Maryland — AgriMetis

AgriMetis, LLC is pleased to announce the opening of its new laboratory in Gaithersburg, Maryland.  The new laboratory is located at 401 Professional Drive, which is in the heart of the Maryland Biotech region along the I-270 corridor.

Read More

Why Roche's $1.9 Billion Deal to Buy Flatiron Health Matters - Fortune

February 19, 2018

The big headline out of the health care M&A world today is Swiss pharmaceutical giant Roche’s $1.9 billion acquisition of Flatiron Health, the Alphabet-backed, cancer-focused digital health analytics upstart that’s attempting to use real world patient information and big data to spur better oncology R&D.

Read More

Startup with Johns Hopkins roots raising $40.5 million to develop cancer metabolism drugs – Endpoints News

February 5, 2018

A new oncology company spun out of Johns Hopkins School of Medicine is raising up to $40.5 million to develop its platform of anticancer therapies.

Read More

Qiagen Gets FDA OK for Expanded Use of EGFR CDx for Lung Cancer Drug - GenomeWeb

January 22, 2018

Qiagen said today that the US Food and Drug Administration has extended the indications for use of its Therascreen EGFR RGQ PCR kit to guide the use of Boehringer Ingelheim's Gilotrif (afatanib) for first-line treatment of patients with metastatic non-small cell lung cancer harboring non-resistant EGFR mutations.

Read More

Rexahn Pharmaceuticals Reports Full Year 2017 Financial Results

March 12, 2018

Rexahn Pharmaceuticals, Inc. (NYSE American:RNN), a clinical stage biopharmaceutical company developing innovative, targeted therapeutics for the treatment of cancer, today announced financial results for the year ended December 31, 2017.

Read More

Machfu Announces Release of MACH-3 Industrial Internet of Things Platform and Gateway | Business Wire

January 15, 2018

Machfu, an Industrial Internet of Things (IIoT) technology company, announced today the release of its MACH-3 IIoT Gateway, a device allowing companies in energy, water, oil and gas as well as other industrial segments to seamlessly connect legacy infrastructure to cloud based IoT and existing SCADA systems. The product was designed to both simplify the connection and management of devices as well as provide a secure and easily customizable application framework to process and manage data at the network edge. The versatile functionalities of the MACH-3 IIoT Gateway will be demonstrated at the 2018 DistribuTECH show, January 22-25 in San Antonio, Texas.

Read More

Top 50 NIH-Funded Institutions of 2018 | The Lists | GEN

June 4, 2018

The National Institutes of Health (NIH) invests nearly $37.3 billion annually in medical research. More than 80% of the funding is awarded through nearly 50,000 competitive grants to more than 300,000 researchers at more than 2500 universities, medical schools, and other research institutions in every U.S. state and around the world.

Read More

Innovation for Impact Prize - SoBran, Inc.

February 27, 2018

Tell us about the impact your research may make on the world. You could win a free pre-clinical research study valued up to $20,000 and $1,000 in cash, or additional cash prizes.

SoBran and the Maryland Tech Council are celebrating the transformational science coming out of the Maryland and surrounding area by establishing the Innovation for Impact Prize.

Read More

Home | About BHI | BHI News | Programs | Partners | Contact

Copyright © BioHealth Innovation 2017
All Rights Reserved.